In a recent article, Hakado et al. suggested that the elevation of AFP and DCP levels at 24 wk after the completion of IFN and ribavirin therapy were strongly associated with the incidence of HCC irrespective of virological response among Japanese patients with cirrhosis [118]. The gene discussed is AFP; the disease is hepatocellular carcinoma.